🇺🇸 FDA
Patent

US 10639277

Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma

granted A61KA61K9/0009A61K9/1271

Quick answer

US patent 10639277 (Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma) held by The Board of Regents of the University of Texas System expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K9/0009, A61K9/1271